Oncology & Cancer

Right program could turn immune cells into cancer killers

Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different "program" that makes them less effective than immune cells in patients whose cancers ...

Oncology & Cancer

Lung cancer: Hope for increasing immunotherapy efficacy

Lung cancer is the leading cause of cancer-related death. Current treatments employ immunotherapy, often in combination with chemotherapy, but benefits to patients remain slight. In a pre-clinical study, EPFL researchers ...

Oncology & Cancer

Anti-tumor agent from the intestine

The microbiome is the vast collection of bacteria in the human gut. It is estimated that each person carries around 100 trillion bacterial cells in their digestive tract, belonging to several thousand species. These are believed ...

Immunology

Predicting whether bowel cancers will respond to immunotherapy

Scientists from the Francis Crick Institute and King's College London have studied colorectal cancer and found that levels of specific immune cells are the best predictors of whether immunotherapy will be effective in individual ...

Oncology & Cancer

Radiation may contribute to personalized cancer vaccine

Radiation therapy appears to increase the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine and NewYork-Presbyterian investigators. ...

Oncology & Cancer

Cancer: A new killer lymphocyte enters the ring

Treatments for beating tumors are mainly based on CD8 T lymphocytes, which specialize in detecting and eliminating intracellular infections and in killing cancer cells. A large proportion of patients, however, do not respond ...

Oncology & Cancer

The role of T cells in fighting cancer

New research from CU Cancer Center member Jing Hong Wang, MD, Ph.D., and recent University of Colorado Immunology program graduate Rachel Woolaver, Ph.D., may help researchers develop more effective personalized immunotherapy ...

page 2 from 12